Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Khalil EA, et al. Among authors: modabber f. Clin Exp Immunol. 2005 May;140(2):349-53. doi: 10.1111/j.1365-2249.2005.02768.x. Clin Exp Immunol. 2005. PMID: 15807861 Free PMC article. Clinical Trial.
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM. Kamil AA, et al. Among authors: modabber f. Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):365-8. doi: 10.1016/s0035-9203(03)90171-4. Trans R Soc Trop Med Hyg. 2003. PMID: 15228261 Clinical Trial.
Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.
Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM; Leishmaniasis Research Group/Sudan. Musa AM, et al. Among authors: modabber f. Trans R Soc Trop Med Hyg. 2008 Jan;102(1):58-63. doi: 10.1016/j.trstmh.2007.08.006. Epub 2007 Oct 25. Trans R Soc Trop Med Hyg. 2008. PMID: 17963805 Clinical Trial.
A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.
Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F. Momeni AZ, et al. Among authors: modabber f. Vaccine. 1999 Feb 5;17(5):466-72. doi: 10.1016/s0264-410x(98)00220-5. Vaccine. 1999. PMID: 10073725 Clinical Trial.
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial.
Vélez ID, del Pilar Agudelo S, Arbelaez MP, Gilchrist K, Robledo SM, Puerta JA, Zicker F, Berman J, Modabber F. Vélez ID, et al. Among authors: modabber f. Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):698-703. doi: 10.1016/s0035-9203(00)90239-6. Trans R Soc Trop Med Hyg. 2000. PMID: 11198661 Clinical Trial.
76 results